Company Filing History:
Years Active: 2009-2011
Title: Innovations in Cancer Detection by Douglas J Rowland
Introduction
Douglas J Rowland is a prominent inventor based in Davis, CA (US). He has made significant contributions to the field of cancer detection through his innovative research and patented technologies. With a total of 2 patents, Rowland's work focuses on the detection of cancer cells and the imaging of solid tumors.
Latest Patents
Rowland's latest patents include groundbreaking methods for detecting cancer cells in vitro using sigma-2 receptor ligands as radiotracers. These methods involve contacting a tissue sample with a radiolabeled compound, allowing for the detection of cancer cells based on the distribution of the radioisotope. His second patent introduces novel benzamide compounds as sigma-2 receptor radiotracers for imaging the proliferative status of solid tumors. This method enables the diagnosis of tumors in mammals by administering a detectable amount of the benzamide compound and imaging the binding to the tumor.
Career Highlights
Rowland's career is marked by his dedication to advancing cancer diagnostics. His innovative approaches have the potential to improve early detection and treatment outcomes for patients. He is affiliated with Washington University, where he continues to contribute to research in this critical area.
Collaborations
Rowland has collaborated with notable colleagues, including Robert H Mach and Michael John Welch. These partnerships have further enhanced the impact of his research and innovations in cancer detection.
Conclusion
Douglas J Rowland's contributions to cancer detection through his patented technologies represent a significant advancement in medical diagnostics. His work continues to pave the way for improved methods in identifying and treating cancer, ultimately benefiting patients and the medical community.